The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis
Open accessAbstract
OBJECTIVE: To provide a comprehensive overview of the risk of venous thrombosis in women using different combined oral contraceptives. DESIGN: Systematic review and network meta-analysis. DATA SOURCES: PubMed, Embase, Web of Science, Cochrane, Cumulative Index to Nursing and Allied Health Literature, Academic Search Premier, and ScienceDirect up to 22 April 2013. REVIEW METHODS: Observational studies that assessed the effect of combined oral contraceptives on venous thrombosis in healthy women. The primary outcome of interest was a fatal or non-fatal first event of venous thrombosis with the main focus on deep venous thrombosis or pulmonary embolism. Publications with at least 10 events in total were eligible. The network meta-analysis was performed using an extension of frequentist random effects models for mixed multiple treatment comparisons. Unadjusted relative risks with 95% confidence intervals were reported. The requirement for crude numbers did not allow adjustment for potential confounding variables. RESULTS: 3110 publications were retrieved through a search strategy; 25 publications reporting on 26 studies were included. Incidence of venous thrombosis in non-users from two included cohorts was 1.9 and 3.7 per 10,000 woman years, in line with previously reported incidences of 1-6 per 10,000 woman years. Use of combined oral contraceptives increased the risk of venous thrombosis compared with non-use (relative risk 3.5, 95% confidence interval 2.9 to 4.3). The relative risk of venous thrombosis for combined oral contraceptives with 30-35 µg ethinylestradiol and gestodene, desogestrel, cyproterone acetate, or drospirenone were similar and about 50-80% higher than for combined oral contraceptives with levonorgestrel. A dose related effect of ethinylestradiol was observed for gestodene, desogestrel, and levonorgestrel, with higher doses being associated with higher thrombosis risk. CONCLUSION: All combined oral contraceptives investigated in this analysis were associated with an increased risk of venous thrombosis. The effect size depended both on the progestogen used and the dose of ethinylestradiol.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Incidence and mortality of venous thrombosis: a population‐based study
NÆSS, I. A., CHRISTIANSEN, S. C., ROMUNDSTAD, P., CANNEGIETER, S. C., ROSENDAAL, F. R., & HAMMERSTRØM, J. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02450.x · Cited by 1,413
Self-citationWhite, I. R., Barrett, J. K., Jackson, D., & Higgins, J. P. T. (2012) · Research Synthesis Methods · doi:10.1002/jrsm.1045 · Cited by 1,114
Accuracy of clinical assessment of deep-vein thrombosis
Wells, P., Hirsh, J., Anderson, D., Lensing, A. A., Foster, G., Kearon, C., Weitz, J., D'Ovidio, R., Cogo, A., Prandoni, P., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92535-x · Cited by 798
Hormonal contraception and risk of venous thromboembolism: national follow-up study
Lidegaard, O., Lokkegaard, E., Svendsen, A. L., & Agger, C. (2009) · BMJ · doi:10.1136/bmj.b2890 · Cited by 709
van Hylckama Vlieg, A., Helmerhorst, F. M., Vandenbroucke, J. P., Doggen, C. J. M., & Rosendaal, F. R. (2009) · BMJ · doi:10.1136/bmj.b2921 · Cited by 666
Self-citationInman, W. H. W., Vessey, M. P., Westerholm, B., & Engelund, A. (1970) · BMJ · doi:10.1136/bmj.2.5703.203 · Cited by 611
Lidegaard, O., Nielsen, L. H., Skovlund, C. W., Skjeldestad, F. E., & Lokkegaard, E. (2011) · BMJ · doi:10.1136/bmj.d6423 · Cited by 608
Bloemenkamp, K. W. M., Helmerhorst, F. M., Rosendaal, F. R., Vandenbroucke, J. P., & Büller, H. R. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91929-5 · Cited by 580
Self-citationOral Contraceptives and the Risk of Venous Thrombosis
Vandenbroucke, J. P., Rosing, J., Bloemenkamp, K. W. M., Middeldorp, S., Helmerhorst, F. M., Bouma, B. N., & Rosendaal, F. R. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105173442007 · Cited by 579
Self-citationWu, O., Robertson, L., Twaddle, S., Lowe, G., Clark, P., Greaves, M., Walker, I., Langhorne, P., Brenkel, I., Regan, L., et al. (2006) · Health Technology Assessment · doi:10.3310/hta10110 · Cited by 489
Investigation of relation between use of oral contraceptives and thromboembolic disease.
Vessey, M. P., & Doll, R. (1968) · BMJ · doi:10.1136/bmj.2.5599.199 · Cited by 470
Third generation oral contraceptives and risk of venous thrombosis: meta-analysis
Kemmeren, J. M., Algra, A., & Grobbee, D. E. (2001) · BMJ · doi:10.1136/bmj.323.7305.131 · Cited by 455
Inman, W. H., & Vessey, M. P. (1968) · BMJ · doi:10.1136/bmj.2.5599.193 · Cited by 452
Compared to what? Finding controls for case-control studies
Grimes, D. A., & Schulz, K. F. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66379-9 · Cited by 418
Poulter, N. R., Cl, C., Farley, T., Meirik, O., & Marmot, M. G. (1995) · PubMed · Cited by 404
Vessey, M. P., & Doll, R. (1969) · BMJ · doi:10.1136/bmj.2.5658.651 · Cited by 403
THROMBOEMBOLISM AND ORAL CONTRACEPTIVERS: AN EPIDEMIOLOGIC CASE-CONTROL STUDY12
SARTWELL, P. E., MASI, A. T., ARTHES, F. G., GREENE, G. R., & SMITH, H. E. (1969) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a121082 · Cited by 342
Oral contraceptives and venous thromboembolism: a five-year national case-control study☆
Lidegaard, Ø., Edström, B., & Kreiner, S. (2002) · Contraception · doi:10.1016/s0010-7824(01)00307-9 · Cited by 334
Farley, T., Meirik, O., Cl, C., Marmot, M. G., & Poulter, N. R. (1995) · PubMed · Cited by 319
Meade, T. W., Greenberg, G., & Thompson, S. G. (1980) · BMJ · doi:10.1136/bmj.280.6224.1157 · Cited by 309
Oral contraceptives and venous thromboembolism: findings in a large prospective study.
Vessey, M., Mant, D., Smith, A., & Yeates, D. (1986) · BMJ · doi:10.1136/bmj.292.6519.526 · Cited by 259
Jick, S. S., & Hernandez, R. K. (2011) · BMJ · doi:10.1136/bmj.d2151 · Cited by 238
Parkin, L., Sharples, K., Hernandez, R. K., & Jick, S. S. (2011) · BMJ · doi:10.1136/bmj.d2139 · Cited by 203
Nelson, E., O'Meara, S., Craig, D., Iglesias, C., Golder, S., Dalton, J., Claxton, K., Bell-Syer, S., Jude, E., Dowson, C., et al. (2006) · Health Technology Assessment · doi:10.3310/hta10120 · Cited by 201
THROMBOSIS WITH LOW-ESTROGEN ORAL CONTRACEPTIVES
STOLLEY, P. D., TONASCIA, J. A., TOCKMAN, M. S., SARTWELL, P. E., RUTLEDGE, A. H., & JACOBS, M. P. (1975) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112148 · Cited by 187
Lewis, M. A., Heinemann, L. A. J., MacRae, K. D., Bruppacher, R., & Spitzer, W. O. (1996) · Contraception · doi:10.1016/0010-7824(96)00112-6 · Cited by 183
Goodacre, S., Sampson, F., Stevenson, M., Wailoo, A., Sutton, A., Thomas, S., Locker, T., & Ryan, A. (2006) · Health Technology Assessment · doi:10.3310/hta10150 · Cited by 180
van Hylckama Vlieg, A., Helmerhorst, F. M., & Rosendaal, F. R. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.211482 · Cited by 175
Self-citationMartinelli, I., Taioli, E., Bucciarelli, P., Akhavan, S., & Mannucci, P. M. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.700 · Cited by 172
Kemmeren, J. M., Algra, A., Meijers, J. C. M., Tans, G., Bouma, B. N., Curvers, J., Rosing, J., & Grobbee, D. E. (2004) · Blood · doi:10.1182/blood-2003-04-1285 · Cited by 157
Bloemenkamp, K. W. M., Rosendaal, F. R., Buller, H. R., Helmerhorst, F. M., Colly, L. P., & Vandenbroucke, J. P. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.1.65 · Cited by 141
Self-citationGronich, N., Lavi, I., & Rennert, G. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.110463 · Cited by 135
20 µg versus >20 µg estrogen combined oral contraceptives for contraception
Gallo, M. F., Nanda, K., Grimes, D. A., Lopez, L. M., & Schulz, K. F. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003989.pub5 · Cited by 133
Farmer, R. D. T., Lawrenson, R. A., Todd, J. ‐., Williams, T. J., MacRae, K. D., Tyrer, F., & Leydon, G. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00198.x · Cited by 130
Venous thromboembolism amng new users of different oral contraceptives.
Herings, R. M. C., Urquhart, J., & Leufkens, H. G. M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01257-x · Cited by 115
Oral contraceptives and fatal pulmonary embolism
Parkin, L., Skegg, D. C. G., Wilson, M., Herbison, P., & Paul, C. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02382-5 · Cited by 100
Thromboembolic disease and the steroidal content of oral contraceptives.
Gi, S. (1970) · PubMed · Cited by 100
Oral Contraceptives and Venous Thromboembolism: A Systematic Review and Meta-Analysis
Manzoli, L., Vito, C. D., Marzuillo, C., Boccia, A., & Villari, P. (2012) · Drug Safety · doi:10.2165/11598050-000000000-00000 · Cited by 98
van Vliet, H. A. A. M., Frölich, M., Thomassen, S., Thomassen, S., Doggen, C. J. M., Rosendaal, F. R., Rosing, J., & Helmerhorst, F. M. (2004) · Human Reproduction · doi:10.1093/humrep/deh612 · Cited by 89
Self-citationSex hormone‐binding globulin as a marker for the thrombotic risk of hormonal contraceptives
Raps, M., Helmerhorst, F. M., Fleischer, K., Thomassen, S., Rosendaal, F. R., Rosing, J., Ballieux, B. E. P. B., & van Vliet, H. A. A. M. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04720.x · Cited by 87
Self-citationComparison of Recalled and Validated Oral Contraceptive Histories
NISCHAN, P., EBELING, K., Thomas, D. B., & Hirsch, U. (1993) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116907 · Cited by 82
Progestins and Antiprogestins in Clinical Practice
Sitruk-Ware, L. R., & Mishell, D. R. (1999) · Medical Entomology and Zoology · Cited by 71
Vandenbroucke, J. P., Helmerhorst, F. M., Bloemenkamp, K. W. M., & Rosendaal, F. R. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70289-8 · Cited by 70
Self-citationJick, S. S., Kaye, J. A., Russmann, S., & Jick, H. (2006) · Contraception · doi:10.1016/j.contraception.2006.02.002 · Cited by 69
Hammersmith postgraduate association.
Brain, M. C., & Vickers, M. (1967) · PubMed · Cited by 67
Kemmeren, J. M., Meijers, J. C. M., Bouma, B. N., Grobbee, D. E., & Algra, A. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1612973 · Cited by 63
Todd, J. ‐., Lawrenson, R. A., Farmer, R. D. T., Williams, T. J., & Leydon, G. (1999) · Human Reproduction · doi:10.1093/humrep/14.6.1500 · Cited by 61
Andersen, B. S., Olsen, J., Nielsen, G. L., Steffensen, F. H., Sørensen, H. T., Bæch, J., & Gregersen, H. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614213 · Cited by 57
Oral contraceptive use: interview data versus pharmacy records
Norell, S. E. (1998) · International Journal of Epidemiology · doi:10.1093/ije/27.6.1033 · Cited by 56
Farmer, R. D. T., Todd, J. ‐., Lewis, M. A., MacRae, K. D., & Williams, T. J. (1998) · Contraception · doi:10.1016/s0010-7824(98)00002-x · Cited by 49
Dungan, J. S. (2010) · Yearbook of Obstetrics Gynecology and Women s Health · doi:10.1016/s1090-798x(10)79320-6 · Cited by 46
Fluorouracil and folinic acid in colon cancer
Hughes‐Davies, L., Rescigno, J., & Marsoni, S. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91136-7 · Cited by 45
Combined oral contraceptives: risks and benefits
Thorogood, M., & VILLARD‐MACKINTOSH, L. (1993) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a072592 · Cited by 41
Heinemann, L. A. J., Dinger, J. C., Assmann, A., & Minh, T. D. (2010) · Contraception · doi:10.1016/j.contraception.2009.12.014 · Cited by 39
Heinemann, L. A. J., Lewis, M. A., Assmann, A., et al. (2002) · Contraception · doi:10.1016/s0010-7824(01)00309-2 · Cited by 37
Hedenmalm, K., Samuelsson, E. C., & Spigset, O. (2004) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/j.0001-6349.2004.0533.x · Cited by 26
(1996) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(96)89712-8 · Cited by 24
(1996) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(96)89713-x · Cited by 24
Bird, S. T., Delaney, J. A. C., Etminan, M., Brophy, J. M., & Hartzema, A. G. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12224 · Cited by 22
Stockman, J. A. (2012) · Yearbook of Pediatrics · doi:10.1016/j.yped.2011.09.005 · Cited by 10
Cited by
Hutton, B., Salanti, G., Caldwell, D. M., Chaimani, A., Schmid, C. H., Cameron, C., Ioannidis, J. P. A., Straus, S., Thorlund, K., Jansen, J. P., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2385 · Cited by 8,269
Martin, K. A., Chang, R. J., Ehrmann, D. A., Ibanez, L., Lobo, R. A., Rosenfield, R. L., Shapiro, J., Montori, V. M., & Swiglo, B. A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2437 · Cited by 512
Martin, K. A., Anderson, R. R., Chang, R. J., Ehrmann, D. A., Lobo, R. A., Murad, M. H., Pugeat, M. M., & Rosenfield, R. L. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00241 · Cited by 339
Dragoman, M. V., Tepper, N. K., Fu, R., Curtis, K. M., Chou, R., & Gaffield, M. E. (2018) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12455 · Cited by 253
Hormonal contraceptives: pharmacology tailored to women's health
De Leo, V., Musacchio, M. C., Cappelli, V., Piomboni, P., & Morgante, G. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw016 · Cited by 188
Metadata
- Authors
- Stegeman, B. H., de Bastos, M., Rosendaal, F. R., van Hylckama Vlieg, A., Helmerhorst, F. M., Stijnen, T., & Dekkers, O. M.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2013-09-12
- Volume
- 347
- Issue
- sep12 1
- Pages
- f5298-f5298
- ISSN
- 1756-1833 (ISSN-L)
- OpenAlex
- W2153137569
- Cited by
- 420
- References
- 60
- FWCI
- 6.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.